Lebensztejn DM - Search Results

1

Cytokeratin-18 and hyaluronic acid levels predict liver fibrosis in children with non-alcoholic fatty liver disease.

Lebensztejn DM, Wierzbicka A, Socha P, Pronicki M, Skiba E, Werpachowska I, Kaczmarski M. Lebensztejn DM, et al. Acta Biochim Pol. 2011;58(4):563-6. Epub 2011 Dec 3. Acta Biochim Pol. 2011. PMID: 22140659

2

Serum laminin-2 and hyaluronan predict severe liver fibrosis in children with chronic hepatitis B.

Lebensztejn DM, Kaczmarski M, Sobaniec-Łotowska M, Bauer M, Voelker M, Schuppan D. Lebensztejn DM, et al. Hepatology. 2004 Mar;39(3):868-9. doi: 10.1002/hep.20147. Hepatology. 2004. PMID: 14999715 No abstract available.

3

Serum cystatin C concentration does not predict advanced liver disease in children with chronic hepatitis B.

Lebensztejn DM, Skiba E, Kaczmarski M, Tobolczyk J, Koput A, Sobaniec-Łotowska ME. Lebensztejn DM, et al. Clin Chim Acta. 2004 Sep;347(1-2):227-8. doi: 10.1016/j.cccn.2004.03.029. Clin Chim Acta. 2004. PMID: 15313163 No abstract available.

4

A simple noninvasive index (APRI) predicts advanced liver fibrosis in children with chronic hepatitis B.

Lebensztejn DM, Skiba E, Sobaniec-Lotowska M, Kaczmarski M. Lebensztejn DM, et al. Hepatology. 2005 Jun;41(6):1434-5. doi: 10.1002/hep.20736. Hepatology. 2005. PMID: 15915470 No abstract available.

5

Serum fibrosis markers as predictors of an antifibrotic effect of interferon alfa in children with chronic hepatitis B.

Lebensztejn DM, Sobaniec-Łotowska ME, Bauer M, Kaczmarski M, Voelker M, Schuppan D. Lebensztejn DM, et al. Eur J Gastroenterol Hepatol. 2005 Aug;17(8):843-8. doi: 10.1097/00042737-200508000-00011. Eur J Gastroenterol Hepatol. 2005. PMID: 16003134

6

Chronic non-cholestatic liver disease is not associated with an increased fracture rate in children.

Konstantynowicz J, Lebensztejn DM, Skiba E, Sobaniec-Lotowska ME, Abramowicz P, Piotrowska-Jastrzebska J, Kaczmarski M. Konstantynowicz J, et al. Among authors: lebensztejn dm. J Bone Miner Metab. 2011 May;29(3):315-20. doi: 10.1007/s00774-010-0219-7. Epub 2010 Sep 14. J Bone Miner Metab. 2011. PMID: 20838830

7

Retinol binding protein-4 as a serum biomarker of intrahepatic lipid content in obese children--preliminary report.

Romanowska A, Lebensztejn DM, Skiba E, Tarasów E, Kaczmarski M. Romanowska A, et al. Among authors: lebensztejn dm. Acta Biochim Pol. 2011;58(1):35-8. Epub 2011 Mar 7. Acta Biochim Pol. 2011. PMID: 21383997

8

[Frequency and causes for hospitalization of children with cholelithiasis - own observations].

Uścinowicz M, Kowalczuk-Krystoń M, Bobrus-Chociej A, Lebensztejn D, Kaczmarski M. Uścinowicz M, et al. Med Wieku Rozwoj. 2011 Oct-Dec;15(4):467-71. Med Wieku Rozwoj. 2011. PMID: 22516703 Polish.

9

Omega-3 fatty acids for treatment of non-alcoholic fatty liver disease: design and rationale of randomized controlled trial.

Janczyk W, Socha P, Lebensztejn D, Wierzbicka A, Mazur A, Neuhoff-Murawska J, Matusik P. Janczyk W, et al. BMC Pediatr. 2013 May 23;13:85. doi: 10.1186/1471-2431-13-85. BMC Pediatr. 2013. PMID: 23702094 Free PMC article. Clinical Trial.

10

Serum fetuin A concentration is elevated in children with non-alcoholic fatty liver disease.

Lebensztejn DM, Białokoz-Kalinowska I, Kłusek-Oksiuta M, Tarasów E, Wojtkowska M, Kaczmarski M. Lebensztejn DM, et al. Adv Med Sci. 2014 Mar;59(1):81-4. doi: 10.1016/j.advms.2013.08.003. Epub 2014 Mar 22. Adv Med Sci. 2014. PMID: 24797980

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

122 results

Search Page

Filters